# Program 1 Architecture Review Track Phase F - Security, Authorization, and Audit Conceptual Boundary

Status: documentation-only, synthetic-only, non-production, non-runtime, pre-implementation, conceptual security/authorization/audit boundary. Not a runtime security module, not a runtime authorization module, not a runtime audit module, and not an approval, clearance, or override implementation.

## Purpose

Program 1 Architecture Review Track Phase F defines conceptual security, authorization, and audit boundaries for any possible future Program 1 implementation discussion.

Phase F follows Architecture Review Track Phase A, Phase B, Phase C, Phase D, and Phase E. It is not Phase Z+1 and is not a return to the Phase V-Z governance/prototype sequence.

Program 1 remains in pre-implementation hold.

## Track continuity

Phase A established the synthetic-only architecture boundary. Phase B established conceptual module separation. Phase C established conceptual synthetic data-flow traces. Phase D established a conceptual read-only reference boundary and strict non-mutation model. Phase E established human-in-the-loop responsibility and clinical accountability boundaries. Phase F clarifies that security, authorization, RBAC, audit, policy enforcement, approval gates, clearance gates, and override gates are future conceptual areas only.

## Scope

- Security conceptual boundary.
- Authorization and RBAC conceptual boundary.
- Audit conceptual boundary.
- Policy enforcement prohibition.
- Approval, clearance, and override prohibition.
- Security/auth/audit dependency map.
- Conceptual control matrix.

## Non-scope

Phase F does not add runtime code, tests, helpers, scripts, imports, services, database migrations, API endpoints, UI flows, schedulers, task runners, integrations, data connectors, real-data ingestion, PHI/PII processing, read-only runtime access, database queries, EHR/EMR access, clinical decision execution, autonomous diagnosis, autonomous treatment, patient instruction delivery, clinician-facing executable recommendations, runtime authentication, runtime authorization, runtime access control, runtime policy enforcement, runtime auth/authz/RBAC, audit logging runtime behavior, audit event capture, audit event storage, access log capture, patient messaging, appointment mutation, workflow enforcement, Task engine, Outcome Evidence, clinical write workflows, approval/clearance/override runtime capability, approval gate implementation, clearance gate implementation, override gate implementation, production-readiness claim, or go-live authorization.

## Safety boundaries

Phase F is documentation-only, synthetic-only, non-production, non-runtime, pre-implementation, conceptual only, not an implementation authorization, not a production-readiness review, not a clinical deployment review, not a runtime security module, not a runtime authorization module, not a runtime audit module, and not an approval, clearance, or override implementation.

Phase F does not approve production use, real patient data, PHI/PII processing, live clinical deployment, clinical validation, operational clearance, go-live, runtime implementation, runtime read-only access, runtime data flow, database queries, EHR/EMR access, patient record viewing, real-data inspection, runtime authentication, runtime authorization, RBAC enforcement, policy enforcement, audit event capture, audit event storage, access log capture, clinical decision execution, autonomous diagnosis, autonomous treatment, patient instruction delivery, patient messaging, appointment mutation, workflow enforcement, or approval/clearance/override behavior.

## Phase A/B/C/D/E input summary

Phase A established synthetic-only architecture boundaries, permitted future discussion areas, prohibited runtime paths, data classification preview, read-only vs write-capable conceptual distinction, human-in-the-loop responsibility preview, and a future approval dependency map.

Phase B established conceptual module separation, the synthetic documentation layer boundary, future read-only layer boundary, future clinical review layer boundary, prohibited write-capable layer boundary, prohibited patient communication boundary, prohibited appointment mutation boundary, deferred security/audit/authorization layer, and prohibited coupling map.

Phase C established the synthetic entity model, conceptual data-flow model, allowed synthetic trace paths, prohibited real-data flow paths, read-only conceptual flow boundary, write-back and mutation prohibition trace, security/audit/auth conceptual flow limits, and boundary trace matrix.

Phase D established the conceptual read-only reference boundary, non-mutation model, prohibited read access paths, prohibited write-back and mutation paths, read-only vs operational access distinction, and synthetic reference trace matrix.

Phase E established the human-in-the-loop responsibility model, clinical accountability boundary, autonomous clinical behavior prohibition, clinician review and decision separation, patient instruction and communication prohibition, accountability dependency map, and clinical boundary matrix.

## Security conceptual boundary

Security is a future conceptual architecture domain only. It may be discussed as security principles, threat categories, conceptual trust boundaries, data isolation concepts, least-privilege concepts, future security review dependencies, and non-runtime architecture notes.

Phase F must not create runtime security enforcement, production access, real secrets handling, credentials, keys, tokens, access policies, deployed controls, network controls, security middleware, integration security, or incident automation.

## Authorization and RBAC conceptual boundary

Authorization and RBAC are future conceptual areas only. Phase F does not implement users, roles, permissions, access grants, access denial behavior, policy engines, runtime authorization checks, runtime authentication, session management, privilege escalation handling, emergency access, break-glass access, approval gates, clearance gates, or override gates.

Permitted discussion is limited to future role taxonomy, future access boundary categories, future separation-of-duties concepts, future authorization review dependency, future privacy/legal dependency, and future clinical governance dependency.

## Audit conceptual boundary

Audit is a future conceptual area only. Phase F does not implement audit logging, audit event capture, audit event storage, access logging, patient data access logs, clinical action logs, approval logs, override logs, retention policies, audit dashboards, audit exports, incident triggers, or monitoring integrations.

Permitted discussion is limited to future audit event taxonomy, future accountability trace concept, future review dependency, future retention/privacy dependency, and future incident response dependency.

## Policy enforcement prohibition

Phase F does not create policy enforcement. Runtime policy checks, access enforcement, workflow enforcement, clinical pathway enforcement, patient communication enforcement, appointment mutation enforcement, approval enforcement, clearance enforcement, override enforcement, deployment enforcement, and go-live enforcement remain prohibited.

## Approval, clearance, and override prohibition

Phase F explicitly prohibits approval gate implementation, clearance gate implementation, override gate implementation, production approval workflow, real-data approval workflow, PHI/PII approval workflow, clinical clearance workflow, go-live approval workflow, emergency override workflow, break-glass workflow, and human override execution path.

Approval, clearance, and override may be mentioned only as future governance dependencies, not as system capabilities.

## Security/auth/audit dependency map

| Area | Current Phase F status | Unresolved dependency | Prohibited current action | Required future review | Current decision |
| --- | --- | --- | --- | --- | --- |
| Security architecture | Conceptual only | Security architecture review | Implement security controls | Security review | Deferred |
| Privacy/legal review | Not performed | Privacy/legal governance | Process PHI/PII | Privacy/legal review | Deferred |
| Production access governance | Not performed | Production access model | Grant production access | Production governance review | Deferred |
| Real-data governance | Not performed | Real-data approval path | Ingest real data | Data governance review | Deferred |
| PHI/PII governance | Not performed | PHI/PII approval path | Process PHI/PII | Privacy/legal review | Deferred |
| Authentication | Conceptual only | Auth architecture | Implement runtime authentication | Security review | Deferred |
| Authorization | Conceptual only | Authorization architecture | Implement runtime authorization | Security review | Deferred |
| RBAC | Conceptual only | Role and permission model | Enforce RBAC | Security and governance review | Deferred |
| Audit logging | Conceptual only | Audit architecture | Capture runtime audit events | Audit/security review | Deferred |
| Access logging | Conceptual only | Access log model | Capture access logs | Audit/security review | Deferred |
| Clinical accountability audit | Conceptual only | Clinical accountability model | Claim clinical traceability | Clinical governance review | Deferred |
| Incident response | Conceptual only | Incident process | Trigger incidents automatically | Operational governance review | Deferred |
| Rollback responsibility | Conceptual only | Rollback model | Execute rollback | Operational governance review | Deferred |
| Approval/clearance/override governance | Conceptual dependency only | Governance authorization | Implement approval or override | Governance review | Prohibited |
| Deployment governance | Not performed | Deployment governance model | Authorize deployment | Production governance review | Deferred |

## Conceptual control matrix

| Control concept | Allowed in Phase F | Prohibited in Phase F | Runtime status | Data status | Enforcement status | Future dependency | Current decision |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Security principle | Conceptual discussion | Runtime control | None | Synthetic only | None | Security review | Allowed as docs only |
| Trust boundary concept | Conceptual discussion | Network or system control | None | Synthetic only | None | Security architecture review | Allowed as docs only |
| Least privilege concept | Conceptual discussion | Access enforcement | None | Synthetic only | None | Authorization review | Deferred |
| Future role taxonomy | Conceptual discussion | User/role implementation | Not implemented | Synthetic only | None | Security/governance review | Deferred |
| Future permission taxonomy | Conceptual discussion | Permission enforcement | Not implemented | Synthetic only | None | Security/governance review | Deferred |
| Authentication concept | Conceptual discussion | Runtime authentication | Not implemented | Synthetic only | None | Security review | Deferred |
| Authorization concept | Conceptual discussion | Runtime authorization | Not implemented | Synthetic only | None | Security review | Deferred |
| RBAC concept | Conceptual discussion | RBAC enforcement | Not implemented | Synthetic only | None | Security/governance review | Deferred |
| Audit event concept | Conceptual discussion | Audit capture/storage | Not implemented | Synthetic only | None | Audit/security review | Deferred |
| Access log concept | Conceptual discussion | Access log capture | Not implemented | Synthetic only | None | Audit/security review | Deferred |
| Incident response concept | Conceptual discussion | Incident automation | Not implemented | Synthetic only | None | Operational review | Deferred |
| Rollback concept | Conceptual discussion | Rollback execution | Not implemented | Synthetic only | None | Operational review | Deferred |
| Approval concept | Future dependency mention | Approval gate | Prohibited | Synthetic only | Prohibited | Governance authorization | Prohibited |
| Clearance concept | Future dependency mention | Clearance gate | Prohibited | Synthetic only | Prohibited | Governance authorization | Prohibited |
| Override concept | Future dependency mention | Override gate | Prohibited | Synthetic only | Prohibited | Governance authorization | Prohibited |
| Policy enforcement concept | Prohibition discussion | Runtime policy enforcement | Prohibited | Synthetic only | Prohibited | Governance and security review | Prohibited |
| Production access concept | Boundary discussion | Production access | Prohibited | None | Prohibited | Production governance review | Prohibited |

## Explicit non-approval statement

Phase F does not approve implementation, production use, real-data use, PHI/PII processing, clinical deployment, go-live, runtime data flow, read-only runtime access, database access, EHR/EMR access, patient record viewing, operational access, runtime authentication, runtime authorization, RBAC enforcement, runtime audit logging, audit event capture, access logging, policy enforcement, clinical decision execution, autonomous diagnosis, autonomous treatment, patient instruction delivery, patient messaging, appointment mutation, workflow enforcement, clinical write workflows, or approval/clearance/override capability.

## Next-step decision

Recommended next phase: `Program 1 Architecture Review Track Phase G - Privacy, PHI/PII, and Real-Data Governance Conceptual Boundary`.

If opened, Phase G should remain documentation-only and synthetic-only. Phase G must not introduce real-data processing, PHI/PII processing, de-identification implementation, privacy tooling, data connectors, production access, or runtime enforcement.

## Closure statement

Architecture Review Track Phase F closes with Program 1 still in pre-implementation hold. No runtime security enforcement, runtime authorization/RBAC, runtime audit logging, audit event capture, access logging, policy enforcement, approval/clearance/override capability, clinical decision execution, autonomous diagnosis/treatment, patient instruction, patient messaging, appointment mutation, real-data ingestion, PHI/PII processing, production approval, clinical deployment, or go-live authorization is created.
